Related Experiment Video
Updated: Feb 5, 2026

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
Published on: September 3, 2021
SRPK1 is a poor prognostic indicator and a novel potential therapeutic target for human colorectal cancer
Nan Yi1,2, Mingbing Xiao1,2, Feng Jiang2
1Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, People's Republic of China, weichangchensz@163.com.
Background:
Serine/arginine protein kinase 1 (SRPK1) is a protein kinase that belongs to the serine/arginine-rich domain family of splicing factors which are essential for splice-site selection, especially the modulation for RNA metabolism, localization, and translation. High expression of SRPK1 has been found in numerous human cancers, but its mechanism in colorectal cancer (CRC) is still rarely reported.
Purpose:
To investigate the expression of SRPK1 in CRC tissues and cells and determine its functions and mechanism in CRC.
Methods:
The expression of SRPK1 was explored in human CRC patients and cells by immunohistochemistry, real-time quantitative PCR, and Western blot; Cell Counting Kit-8, Transwell, flow cytometry, and tube formation assay were used to investigate the CRC cell viability, migration, apoptosis, and angiogenesis, respectively.
Results:
SRPK1 was overexpressed in CRC tumor tissues and cells, and correlated with tumor node metastasis stage; inhibition of SRPK1 by siRNA resulted in decreased cell growth and migration, significantly increased apoptosis, and suppressed angiogenesis.
Conclusion:
SRPK1 can be a prognostic indicator of CRC and may be a therapeutic target for CRC.
Insights
Serine/arginine protein kinase 1 (SRPK1) is overexpressed in colorectal cancer (CRC), promoting tumor growth and metastasis. Inhibiting SRPK1 suppressed CRC progression, suggesting it as a potential therapeutic target for this disease.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Serine/arginine protein kinase 1 (SRPK1) is a key splicing factor involved in RNA metabolism.
- High SRPK1 expression is observed in various human cancers.
- The role of SRPK1 in colorectal cancer (CRC) pathogenesis is not well understood.
Purpose of the Study:
- To examine SRPK1 expression levels in CRC tissues and cells.
- To elucidate the functional role and molecular mechanisms of SRPK1 in CRC progression.
Main Methods:
- Immunohistochemistry, qRT-PCR, and Western blot were used to assess SRPK1 expression.
- Cell Counting Kit-8, Transwell assays, flow cytometry, and tube formation assays evaluated cell viability, migration, apoptosis, and angiogenesis.
- Small interfering RNA (siRNA) was employed to inhibit SRPK1.
Main Results:
- SRPK1 was significantly overexpressed in CRC tissues and cells, correlating with advanced tumor-node-metastasis stage.
- SRPK1 inhibition led to reduced cell proliferation and migration.
- Inhibition of SRPK1 significantly increased apoptosis and suppressed angiogenesis in CRC models.
Conclusions:
- SRPK1 is overexpressed in colorectal cancer and linked to disease progression.
- SRPK1 inhibition demonstrates anti-cancer effects in CRC.
- SRPK1 represents a potential prognostic biomarker and therapeutic target for CRC treatment.
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Indicators
Targeted Cancer Therapies
There are several types of targeted therapies against...
Therapeutic Index
Mechanical Ventilation I: Indication and Settings
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...

